Delivery Order SPE2DR25D2101-SPE2DR26F45LS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Gabapentin 300mg tablets (1,000 count) with a ceiling value of $3,686.74. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by December 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,153.82 delivery order to AmerisourceBergen Drug Corp for the supply of Gabapentin 800 mg tablets (500-count units) with an ultimate completion date of November 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing this work at its corporate office location. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Gabapentin 600 mg, with a firm fixed price ceiling value of $1,294.68. The order was issued on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-competitive delivery order represents pharmaceutical procurement from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of 1,000 units of Gabapentin 300 mg capsules at a ceiling value of $1,982.22. This non-set-aside competitive award is scheduled for completion by October 30, 2025, with performance fulfilled from the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565442175 Gabapentin 800 mg tablets. The $2,527.06 firm-fixed-price contract has an estimated completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 800 mg gabapentin tablets, a generic medication used to treat certain types of nerve pain. The contract has a firm fixed price of $1,320.00 and a completion date of January 30, 2025. The place of performance is Conshohocken, Pennsylvania. This contract is part of a larger...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two hundred seven dollars and forty-five cents to Amerisourcebergen Drug Corporation for gabapentin tablets. As the prime contractor, Amerisourcebergen will supply ninety tablets of six-hundred milligram gabapentin to fulfill requirements under the order. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on September 29, 2023. The Defense...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,412.34, is a Firm Fixed Price Delivery Order for the provision of 4567566182 - Gabapentin 800 mg Tablets, in quantities of 500s. The contract has an ultimate completion date of March 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred ninety-three dollars and sixteen cents to Amerisourcebergen Drug Corporation for 4561815490 gabapentin 800 mg tablets. As the prime contractor, Amerisourcebergen will deliver ninety tablets to a facility in Conshohocken, Pennsylvania by August 16, 2023 to fulfill requirements under the Agency's pharmaceutical supply chain program. No subcontractors or set aside designations were indicated. The order...
- This is a firm fixed-price delivery order worth $2,362.56 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of gabapentin 600 mg tablets. The order has a completion date of September 11, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for providing a wide range of...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F45LSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Gabapentin 800 mg tablets in quantities of 500, with a contract ceiling value of $1,007.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 5, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of medications and medical supplies to support military and federal healthcare systems globally. The parent IDC serves as a flexible procurement vehicle enabling the company to fulfill diverse pharmaceutical needs across multiple therapeutic domains in support of the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 11/4/25 |